The pros and cons of preimplantation genetic testing for aneuploidy (PGT-A): clinical and laboratory perspectives

Fertile Battle

Like Comment

Volume 110, Issue 3, Pages 353–361


Zev Rosenwaks, M.D., Alan H. Handyside, Ph.D., Francesco Fiorentino, Ph.D., Norbert Gleicher, M.D., Richard J. Paulson, M.D., Glenn L. Schattman, M.D., Richard T. Scott Jr., M.D., Michael C. Summers, M.D., Ph.D., Nathan R. Treff, Ph.D., Kangpu Xu, Ph.D.


To contribute to a balanced debate, we invited leading proponents and opponents of preimplantation genetic testing for aneuploidy (PGT-A) to briefly summarize their arguments. Four contributors debate the pros and cons from a clinical perspective, two consider technical aspects related to the validation and accuracy of current methodologies, and finally two consider the implications of chromosomal mosaicism, which has recently been identified using next-generation sequencing–based chromosome copy number analysis.

Read the full text here.

Which argument in this paper would you agree with?
Neither for nor against
Created with Survey Maker

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.